Publication Name	World Journal of Clinical Cases
Manuscript ID	10490
Country	Italy

Received	2014-04-05 18:06
Peer-Review Started	2014-04-07 19:23
To Make the First Decision	2014-05-14 13:40
Return for Revision	2014-05-20 20:34
Revised	2014-07-30 18:02
Second Decision	2014-09-10 13:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-09-10 13:50
Articles in Press	2014-09-10 13:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-10-29 16:06
Publish the Manuscript Online	2014-11-10 12:18

ISSN	2307-8960 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Bevacizumab maintenance in metastatic colorectal cancer: How long?
Manuscript Source	Invited Manuscript
All Author List	Alfonso De Stefano, Roberto Moretto, Chiara Alessandra Cella, Francesco Jacopo Romano, Lucia Raimondo, Giovanni Fiore, Francesca Di Pietro, Stefano Pepe, Sabino De Placido and Chiara Carlomagno
Funding Agency and Grant Number
Corresponding Author	Alfonso De Stefano, MD, PhD, Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Via Sergio Pansini, 5, 80131 Naples, Italy. alfonso.destefano@unina.it
Key Words	Metastatic colorectal cancer; Bevacizumab; Maintenance
Core Tip	A colorectal cancer patient with lung metastases received bevacizumab combined with chemotherapy for six months, and then bevacizumab monotherapy as maintenance treatment for more than three years. The patient achieved a complete response without evidence of side effects. He remains relapse free 58 mo after diagnosis.
Publish Date	2014-11-10 12:18
Citation	De Stefano A, Moretto R, Cella CA, Romano FJ, Raimondo L, Fiore G, Di Pietro F, Pepe S, De Placido S, Carlomagno C. Bevacizumab maintenance in metastatic colorectal cancer: How long? World J Clin Cases 2014; 2(11): 717-723
URL	http://www.wjgnet.com/2307-8960/full/v2/i11/717.htm
DOI	http://dx.doi.org/10.12998/wjcc.v2.i11.717

Full Article (PDF)	WJCC-2-717.pdf
Full Article (Word)	WJCC-2-717.doc
Manuscript File	10490-Review.doc
Answering Reviewers	10490-Answering reviewers.PDF
Copyright License Agreement	10490-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate	10490-Language certificate.pdf
Peer-review Report	10490-Peer review(s).pdf
Scientific Misconduct Check	10490-CrossCheck.jpg
Scientific Editor Work List	10490-Scientific editor work list.pdf